UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: August 3, 2004 (DATE OF EARLIEST EVENT REPORTED) INAMED CORPORATION (Exact name of registrant as specified in its charter) 1-9741 59-0920629 (Commission File Number) (IRS Employer Identification No.) 5540 Ekwill Street, Santa Barbara, CA 93111-2936 (Address of Principal Executive Offices) (Zip Code) (805) 683-6761 (Registrant's telephone number, including are code) ITEM 7. EXHIBITS (c) The following exhibit is being furnished herewith: 99.1 Press Release, dated August 3, 2004, by Inamed Corporation ITEM 12. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION The following information is being provided under Item 12, Results of Operations and Financial Condition. Such information, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934: On August 3, 2004, Inamed Corporation issued a press release regarding the Company's financial results for its second fiscal quarter ended June 30, 2004. The full text of the Company's press release is attached hereto as Exhibit 99.1. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INAMED Corporation Date: August 3, 2004 By: /s/ Robert S. Vaters ------------------------ Robert S. Vaters CHIEF FINANCIAL OFFICER EXHIBIT INDEX 99.1 Press Release, dated August 3, 2004 by INAMED Corporation